Please provide your email address to receive an email when new articles are posted on . “There are no clear data to suggest that allopurinol is detrimental to renal function in patients with gout,” ...
Active ingredient: Febuxostat 40 mg, 80 mg; tabs. Indication: Chronic management of hyperuricemia in patients with gout. Pharmacology: Gout is a chronic condition characterized by attacks, or “flares, ...
Mr. F has a 5-year history of hypertension, for which he has been receiving hydrochlorothiazide. He was on a low-sodium diet. He has also suffered from nephrolithiasis with several calcium oxalate ...
Chicago, IL - Results of a phase 3, randomized, double-blind study show that febuxostat (TAP Pharmaceutical Products) is more effective in lowering serum uric acid than the current standard of care, ...
There was an increase in all-cause mortality among dose escalators (hazard ratio, 1.08; 95% confidence interval, 1.01 to 1.17). Similar effect sizes were seen for incidence of cardiovascular-related ...
AstraZeneca announces top-line results from the Phase III programme of lesinurad in combination with xanthine oxidase inhibitors in gout patients AstraZeneca today announced positive top-line results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results